GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Price-to-Funds-From-Operations

Taisho Pharmaceutical Holdings Co (TSE:4581) Price-to-Funds-From-Operations : (As of May. 14, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.